Game-Changer Study Highlights Sacrix® Success in Spine Health
A recent peer-reviewed study published in The Journal of Spine Surgery could reshape the future of sacroiliac joint (SIJ) fusion. This groundbreaking research demonstrates that the Sacrix® fully threaded screw technology represents a significant advancement over traditional triangular implants, such as SI-Bone's iFuse®.
Unveiling the Study Findings
Conducted by renowned orthopedic spine surgeon Dr. Kingsley R. Chin, the study provides solid evidence that the Sacrix® screw offers superior fixation strength compared to its predecessors. With findings stating that Sacrix® achieves a pullout strength of 814.90 N (±99.4), while the iFuse® only reaches 200.14 N (±14.4), it is clear that Sacrix® leads the market.
Significance of the Results
The study involved rigorous testing using the INSTRON 8874 Bi-Axial Tabletop System, ensuring highly accurate results. The statistical significance of the difference in pullout strength is profound, proving that Sacrix® provides over three times the strength needed for optimal surgical outcomes.
Clinical Observations and Conclusions
Dr. Chin remarked, "This study disrupts a narrative that has dominated for years. We now have scientific proof that our modern, multi-threaded Sacrix® screw delivers superior fixation. It's not just an option—it's the evolution of SIJ fusion technology." This illustrates the shift in clinical practices towards more advanced, efficient methods of surgery.
Why Surgeons Prefer Sacrix®
As demand grows for less invasive outpatient surgical solutions, the design of the Sacrix® implant favors faster procedures while minimizing tissue disruption. Adhering to the LESS Exposure Spine Surgery philosophy, the implant supports optimal anatomical healing.
Surgeons are increasingly looking for reliable solutions that enhance patient outcomes. With reduced surgical time and increased stability, the Sacrix® implant is paving the way for future innovations in spine surgery.
About NANISX and Sacrix®
NANISX, the company behind the Sacrix® implant, is dedicated to creating less invasive spine surgery solutions. Their platform also includes other innovative products like InSpan®, FacetFuse®, and NanoFuse® Biologics, showcasing their commitment to advancing surgical techniques.
Core Design Intent of Sacrix®
The Sacrix® device addresses crucial challenges faced in spinal fusion surgeries:
- Providing strong biomechanical fixation to promote stability and fusion.
- Achieving self-tapping and self-drilling transarticular fixation that effectively stabilizes the SI joint.
- Utilizing a patented titanium multithreaded screw design that facilitates harvesting bone grafts both pre- and post-operatively.
Meet Dr. Kingsley R. Chin
Dr. Chin, a board-certified orthopedic spine surgeon, holds qualifications from Columbia and Harvard. He is no stranger to innovation, having numerous patents and peer-reviewed publications to his name, and continues to lead advancements in the field through KIC Ventures.
Frequently Asked Questions
What does the study reveal about Sacrix® vs iFuse®?
The study confirms that Sacrix® outperforms the iFuse® implant in fixation strength by over 300%.
Why is Sacrix® considered a game-changer?
The screw's innovative design allows for superior anchoring while minimizing invasive procedures, making it a preferable option for surgeons.
Who is Dr. Kingsley R. Chin?
Dr. Chin is an experienced orthopedic spine surgeon and medical innovator deeply involved in advancing spine technology.
What does the LESS™ philosophy entail?
LESS™ focuses on minimizing surgical impact, promoting quicker recovery, and preserving the surrounding anatomy during spinal surgery.
Where can I learn more about NANISX and its products?
NANISX offers a range of orthopedic solutions designed for outpatient surgery, emphasizing innovation and efficiency in spinal health.
